South Korean researchers Thursday announced the creation of 11 custom-made cloned stem cell lines, made for the first time from the skin cells of child and adult patients. The advance is considered a significant refinement of the controversial stem cell technology that opens the door wider for future treatment of such diseases as juvenile diabetes and Parkinson’s.
Office of Strategic Communication